Experienced in Macrophagic Myofasciitis

Thomas Makatsoris

Patra, ESYE23, GR 
Experienced in Macrophagic Myofasciitis
Patra, ESYE23, GR 
OverviewLocationsClinical Research

Overview

Thomas Makatsoris practices in Patra, Greece. Mr. Makatsoris is rated as an Experienced expert by MediFind in the treatment of Macrophagic Myofasciitis. His top areas of expertise are Colorectal Cancer, Lung Cancer, Macrophagic Myofasciitis, and Breast Cancer.

His clinical research consists of co-authoring 54 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Macrophagic Myofasciitis.

Gender
Male

Locations

Patra, ESYE23, Greece
Other Locations
Rio, ESYE23 26504, Greece
Athens, ESYE31, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase Ib-II Study of Ramucirumab Combined With Standard Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma
Phase Ib-II Study of Ramucirumab Combined With Standard Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: Ramucirumab
Study Phase: Phase 1/Phase 2
Phase II Multicenter Single-arm Study Evaluating the Safety and Efficacy of Everolimus as a First-line Treatment in Newly-diagnosed Patients With Advanced GI Neuroendocrine Tumors.
Phase II Multicenter Single-arm Study Evaluating the Safety and Efficacy of Everolimus as a First-line Treatment in Newly-diagnosed Patients With Advanced GI Neuroendocrine Tumors.
Enrollment Status: Terminated
Publish Date: September 03, 2019
Intervention Type: Drug
Study Phase: Phase 2
Phase II Single-arm Study of First Line Treatment With Gemcitabine and Pazopanib in Patients With Inoperable Locally Advanced or Metastatic Biliary Tree Cancer (Cholangiocarcinoma or Gallbladder Carcinoma)
Phase II Single-arm Study of First Line Treatment With Gemcitabine and Pazopanib in Patients With Inoperable Locally Advanced or Metastatic Biliary Tree Cancer (Cholangiocarcinoma or Gallbladder Carcinoma)
Enrollment Status: Terminated
Publish Date: November 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

54 Total Publications

Exploring Bevacizumab's Role in Gynecological Cancers: An Up-to-Date Narrative Review Focusing on Ovarian Cancer.
Exploring Bevacizumab's Role in Gynecological Cancers: An Up-to-Date Narrative Review Focusing on Ovarian Cancer.
Journal: Materia socio-medica
Published: January 01, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Makatsoris's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile